Bell Investment Advisors »

Atrium Therapeutics shares owned by Bell Investment Advisors

Quarter-by-quarter ownership of Atrium Therapeutics (RNA) shares owned by Bell Investment Advisors from 13F filings

Historical chart of Bell Investment Advisors investment in Atrium Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atrium Therapeutics held by Bell Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atrium Therapeutics by Bell Investment Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $27 2 13.50

More positions owned by Bell Investment Advisors

Goldman Sachs Etf Tr Acces Treasury (GBIL)
Schwab Strategic Tr Fundamental Us L (FNDX)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Flexshares Tr Iboxx 3r Targt (TDTT)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Schwab Strategic Tr Fundamental Intl (FNDF)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Ishares Tr Msci Usa Mmentm (MTUM)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Schwab Strategic Tr Fundamental Us S (FNDA)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Invesco Exch Traded Fd Tr Ii S&p500 Low Vol (SPLV)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Ishares Core Msci Emkt (IEMG)

View all positions for Bell Investment Advisors

Top funds holding Atrium Therapeutics

BlackRock
RA Capital Management
Vanguard Capital Management
TIG Advisors
Pentwater Capital Management
Sessa Capital IM
Goldman Sachs Group
Vanguard Portfolio Management
Geode Capital Management
683 Capital Management
Weiss Asset Management LP[1
Cantor Fitzgerald, L. P.
Balyasny Asset Management
Squarepoint Ops
Fort Hoosac Management

View all funds holding Atrium Therapeutics